Informações:
Falhas:
ID
34327
Descrição
Study of the Anti-HCV Drug (BMS-790052) Combined With Peginterferon and Ribavirin in Patients Who Failed Prior Treatment; ODM derived from: https://clinicaltrials.gov/show/NCT01170962
Link
https://clinicaltrials.gov/show/NCT01170962
Palavras-chave
Versões (1)
- 16/01/2019 16/01/2019 -
Titular dos direitos
see on clinicaltrials.gov
Transferido a
16 de janeiro de 2019
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Hepatitis C Virus NCT01170962
Eligibility Hepatitis C Virus NCT01170962
- StudyEvent: Eligibility
Similar models
Eligibility Hepatitis C Virus NCT01170962
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
ID.1
Item
subjects chronically infected with hcv genotype 1
boolean
ID.2
Item
non-responder to prior therapy with peginterferon alfa and ribavirin
boolean
ID.3
Item
hcv rna viral load of ≥ 100,00 iu/ml
boolean
ID.4
Item
results of a liver biopsy ≤ 24 months prior to randomization consistent with chronic hcv infection; for compensated cirrhotics can be any time prior to randomization (compensated cirrhotics will be capped at 10% of randomized study population)
boolean
ID.5
Item
ultrasound, ct scan or mri results 12 months prior to randomization that do not demonstrate hepatocellular carcinoma
boolean
ID.6
Item
body mass index (bmi) of 18 to 35 kg/m2
boolean
ID.7
Item
positive for hepatitis b infection (hbsag) or hiv-1/hiv-2 antibody at screening
boolean
ID.8
Item
evidence of medical condition associated with chronic liver disease other than hcv
boolean
ID.9
Item
evidence of decompensated cirrhosis based on radiologic criteria or biopsy
boolean